BSE Live
Jan 01, 16:01Prev. Close
41.07
Open Price
40.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 01, 15:58Prev. Close
41.07
Open Price
41.07
Bid Price (Qty.)
41.11 (233)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Morepen Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 89.96 | 71.46 | 71.46 | 42.20 | 42.20 | |
| Total Share Capital | 209.61 | 191.11 | 191.11 | 64.50 | 64.50 | |
| Reserves and Surplus | 210.63 | 123.46 | 160.31 | 45.74 | 212.96 | |
| Total Reserves and Surplus | 210.63 | 123.46 | 160.31 | 45.74 | 212.96 | |
| Total Shareholders Funds | 420.24 | 314.58 | 351.42 | 110.24 | 277.46 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 128.45 | 278.63 | 289.25 | 335.29 | 648.99 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 168.34 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 128.45 | 278.63 | 289.25 | 335.29 | 817.33 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 11.29 | 1.82 | 2.52 | 177.50 | 252.03 | |
| Trade Payables | 72.02 | 67.58 | 60.62 | 55.01 | 52.05 | |
| Other Current Liabilities | 11.14 | 12.94 | 0.25 | 0.87 | 1.50 | |
| Short Term Provisions | 3.06 | 2.83 | 2.29 | 1.95 | 1.18 | |
| Total Current Liabilities | 97.50 | 85.17 | 65.68 | 235.33 | 306.76 | |
| Total Capital And Liabilities | 646.19 | 681.08 | 709.06 | 817.92 | 1,401.55 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 458.39 | 499.30 | 543.06 | 588.81 | 632.49 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 458.39 | 499.30 | 543.06 | 588.81 | 632.49 | |
| Non-Current Investments | 121.91 | 121.91 | 121.91 | 121.91 | 121.91 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 192.78 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 1.42 | 1.39 | 1.75 | 1.48 | 3.89 | |
| Total Non-Current Assets | 581.72 | 622.60 | 666.72 | 712.20 | 951.07 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 30.47 | 21.36 | 18.21 | 17.19 | 84.03 | |
| Trade Receivables | 20.57 | 18.52 | 11.02 | 9.41 | 138.46 | |
| Cash And Cash Equivalents | 0.82 | 4.30 | 1.52 | 67.96 | 70.49 | |
| Short Term Loans And Advances | 10.58 | 12.54 | 7.88 | 7.53 | 152.29 | |
| OtherCurrentAssets | 2.04 | 1.76 | 3.71 | 3.64 | 5.20 | |
| Total Current Assets | 64.47 | 58.48 | 42.34 | 105.72 | 450.48 | |
| Total Assets | 646.19 | 681.08 | 709.06 | 817.92 | 1,401.55 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 3.39 | 3.60 | 3.27 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 32.09 | 19.53 | 12.14 | 16.43 | 17.43 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.32 | 0.00 | 0.00 | 0.88 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 2.26 | 0.78 | 0.29 | 0.60 | 0.58 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 40.93 | 27.59 | 6.01 | 20.81 | 67.48 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 121.91 | 121.91 | 121.91 | 121.91 | 121.91 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
26.11.2025
Morepen Lab Consolidated September 2025 Net Sales at Rs 411.58 crore, down 5.97% Y-o-Y
24.11.2025
Morepen Lab Standalone September 2025 Net Sales at Rs 369.53 crore, down 3.69% Y-o-Y
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y
26.11.2025
Morepen Lab Consolidated September 2025 Net Sales at Rs 411.58 crore, down 5.97% Y-o-Y
24.11.2025
Morepen Lab Standalone September 2025 Net Sales at Rs 369.53 crore, down 3.69% Y-o-Y
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y